[1]
|
Czeisler, C.A. (2015) Duration, Timing and Quality of Sleep Are Each Vital for Health, Performance and Safety. Sleep Health, 1, 5-8. https://doi.org/10.1016/j.sleh.2014.12.008
|
[2]
|
Erren, T.C., Morfeld, P., Foster, R.G., et al. (2016) Sleep and Cancer: Synthesis of Experimental Data and Meta-Analyses of Cancer Incidence among Some 1,500,000 Study Individuals in 13 Countries. Chronobiology International, 33, 325-350. https://doi.org/10.3109/07420528.2016.1149486
|
[3]
|
Peterson, D.F. (2016) The Dangers of Sleep Deprivation. Firehouse, 41, No. 12.
|
[4]
|
Chen, X., Beydoun, M.A. and Wang, Y. (2008) Is Sleep Duration Associated with Childhood Obesity? A Systematic Review and Meta-Analysis. Obesity (Silver Spring), 16, 265-274. https://doi.org/10.1038/oby.2007.63
|
[5]
|
Cappuccio, F.P., Taggart, F.M., Kandala, N.B., et al. (2008) Meta-Analysis of Short Sleep Duration and Obesity in Children and Adults. Sleep, 31, 619-626. https://doi.org/10.1093/sleep/31.5.619
|
[6]
|
Wang, Q., Xi, B., Liu, M., et al. (2012) Short Sleep Duration Is Associated with Hypertension Risk among Adults: A Systematic Review and Meta-Analysis. Hypertension Research, 35, 1012-1018. https://doi.org/10.1038/hr.2012.91
|
[7]
|
Guo, X., Zheng, L., Wang, J., et al. (2013) Epidemiological Evidence for the Link between Sleep Duration and High Blood Pressure: A Systematic Review and Meta-Analysis. Sleep Medicine, 14, 324-332.
https://doi.org/10.1016/j.sleep.2012.12.001
|
[8]
|
Cappuccio, F.P., D’Elia, L., Strazzullo, P., et al. (2010) Quantity and Quality of Sleep and Incidence of Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Care, 33, 414-420. https://doi.org/10.2337/dc09-1124
|
[9]
|
Cappuccio, F.P., D’Elia, L., Strazzullo, P., et al. (2010) Sleep Duration and All-Cause Mortality: A Systematic Review and Meta-Analysis of Prospective Studies. Sleep, 33, 585-592. https://doi.org/10.1093/sleep/33.5.585
|
[10]
|
Gallicchio, L. and Kalesan, B. (2009) Sleep Duration and Mortality: A Systematic Review and Meta-Analysis. Journal of Sleep Research, 18, 148-158. https://doi.org/10.1111/j.1365-2869.2008.00732.x
|
[11]
|
Aeschbach, D., Sher, L., Postolache, T.T., et al. (2003) A Longer Biological Night in Long Sleepers than in Short Sleepers. The Journal of Clinical Endocrinology & Metabolism, 88, 26-30. https://doi.org/10.1210/jc.2002-020827
|
[12]
|
Gapstur, S.M., Diver, W.R., Stevens, V.L., et al. (2014) Work Schedule, Sleep Duration, Insomnia, and Risk of Fatal Prostate Cancer. American Journal of Preventive Medicine, 46, S26-S33. https://doi.org/10.1016/j.amepre.2013.10.033
|
[13]
|
Kakizaki, M., Inoue, K., Kuriyama, S., et al. (2008) Sleep Duration and the Risk of Prostate Cancer: The Ohsaki Cohort Study. British Journal of Cancer, 99, 176-178. https://doi.org/10.1038/sj.bjc.6604425
|
[14]
|
Markt, S.C., Flynn-Evans, E.E., Valdimarsdottir, U.A., et al. (2016) Sleep Duration and Disruption and Prostate Cancer Risk: A 23-Year Prospective Study. Cancer Epidemiology, Biomarkers & Prevention, 25, 302-308.
https://doi.org/10.1158/1055-9965.EPI-14-1274
|
[15]
|
Dickerman, B.A., Markt, S.C., Koskenvuo, M., et al. (2016) Sleep Disruption, Chronotype, Shift Work, and Prostate Cancer Risk and Mortality: A 30-Year Prospective Cohort Study of Finnish Twins. Cancer Causes Control, 27, 1361-1370. https://doi.org/10.1007/s10552-016-0815-5
|
[16]
|
Markt, S.C., Grotta, A., Nyren, O., et al. (2015) Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort. Sleep, 38, 1405-1410. https://doi.org/10.5665/sleep.4978
|
[17]
|
Orsini, N., Li, R., Wolk, A., et al. (2012) Meta-Analysis for Linear and Nonlinear Dose-Response Relations: Examples, an Evaluation of Approximations, and Software. American Journal of Epidemiology, 175, 66-73.
https://doi.org/10.1093/aje/kwr265
|
[18]
|
Wijarnpreecha, K., Thongprayoon, C., Panjawatanan, P., et al. (2016) Short Sleep Duration and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Journal of Gastroenterology and Hepatology, 31, 1802-1807. https://doi.org/10.1111/jgh.13391
|
[19]
|
Shen, N., Wang, P. and Yan, W. (2016) Sleep Duration and the Risk of Fatty Liver Disease: A Systematic Review and Meta-Analysis. Scientific Reports, 6, Article No. 31956. https://doi.org/10.1038/srep31956
|
[20]
|
Lu, Y., Tian, N., Yin, J., et al. (2013) Association between Sleep Duration and Cancer Risk: A Meta-Analysis of Prospective Cohort Studies. PLoS ONE, 8, e74723. https://doi.org/10.1371/journal.pone.0074723
|
[21]
|
Zhai, L., Zhang, H. and Zhang, D. (2015) Sleep Duration and Depression among Adults: A Meta-Analysis of Prospective Studies. Depress Anxiety, 32, 664-670. https://doi.org/10.1002/da.22386
|
[22]
|
Shan, Z., Ma, H., Xie, M., et al. (2015) Sleep Duration and Risk of Type 2 Diabetes: A Meta-Analysis of Prospective Studies. Diabetes Care, 38, 529-537. https://doi.org/10.2337/dc14-2073
|
[23]
|
Cappuccio, F.P., Cooper, D., D’Elia, L., et al. (2011) Sleep Duration Predicts Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies. European Heart Journal, 32, 1484-1492.
https://doi.org/10.1093/eurheartj/ehr007
|
[24]
|
Fu, L. and Lee, C.C. (2003) The Circadian Clock: Pacemaker and Tumour Suppressor. Nature Reviews Cancer, 3, 350-361. https://doi.org/10.1038/nrc1072
|
[25]
|
Borjigin, J., Zhang, L.S. and Calinescu, A.A. (2012) Circadian Regulation of Pineal Gland Rhythmicity. Molecular and Cellular Endocrinology, 349, 13-19. https://doi.org/10.1016/j.mce.2011.07.009
|
[26]
|
Tamarkin, L., Danforth, D., Lichter, A., et al. (1982) Decreased Nocturnal Plasma Melatonin Peak in Patients with Estrogen Receptor Positive Breast Cancer. Science, 216, 1003-1005. https://doi.org/10.1126/science.7079745
|
[27]
|
Costa, G., Haus, E. and Stevens, R. (2010) Shift Work and Cancer: Considerations on Rationale, Mechanisms, and Epidemiology. Scandinavian Journal of Work, Environment & Health, 36, 163-179.
https://doi.org/10.5271/sjweh.2899
|
[28]
|
Blask, D.E. (2009) Melatonin, Sleep Disturbance and Cancer risk. Sleep Medicine Reviews, 13, 257-264.
https://doi.org/10.1016/j.smrv.2008.07.007
|
[29]
|
Jung-Hynes, B., Schmit, T.L., Reagan-Shaw, S.R., et al. (2011) Melatonin, a Novel Sirt1 Inhibitor, Imparts Antiproliferative Effects against Prostate Cancer in Vitro in Culture and in Vivo in TRAMP Model. Journal of Pineal Research, 50, 140-149. https://doi.org/10.1111/j.1600-079X.2010.00823.x
|